Activities of Vicky FORD related to 2013/0240(NLE)
Shadow reports (1)
REPORT on the proposal for a Council regulation on the Innovative Medicines Initiative 2 Joint Undertaking PDF (413 KB) DOC (539 KB)
Amendments (7)
Amendment 72 #
Proposal for a Regulation
Recital 8
Recital 8
(8) Research related to the future of medicine shall be undertaken in areas where combination of societal, public health and biomedical industry competitiveness goals requires pooling of resources and fostering collaboration between the public and private sectors, with the involvement of SMEs. The scope of the initiative should be expanded to allthose areas of life science research and innovation where the added value of this instrument can be expected. The areas would be of public health interest, as identified by the World Health Organisation report on priority medicines for Europe and the World, which is currently being updated with the new version expected to be releas updated in 2013. The initiative should consequently seek to involve a broader range of partners, including SMEs and mid-caps, from different sectors (e.g. biomedical imaging, medical information technology, diagnostic and/or animal health industries). A wider participation including meaningful involvement of research organisations, and patient organisations would help to advance the development of new approaches and technologies for the prevention, diagnosis and treatment of diseases with high impact on public health.
Amendment 78 #
Proposal for a Regulation
Recital 14
Recital 14
(14) Participation in indirect actions funded by the IMI2 Joint Undertaking shouldall comply with Regulation (EU) No … /2013 of the European Parliament and of the Council of … 2013 laying down the rules for the participation and dissemination in ‘Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020)’16 . __________________ 16 OJ … [H2020 RfP] OJ … [H2020 RfP]
Amendment 118 #
Proposal for a Regulation
Article 3 – paragraph 1 – subparagraph 1 – point a
Article 3 – paragraph 1 – subparagraph 1 – point a
(a) up to a maximum of EUR 1 500 million to matchbe added to the contribution of EFPIA, or its constituent entities or their affiliated entities;
Amendment 153 #
Proposal for a Regulation
Annex 1 – part 1 – paragraph 1 – point b
Annex 1 – part 1 – paragraph 1 – point b
(b) to regularly review and make any necessary adjustments to the Strategic Research Agenda of the IMI2 Joint Undertaking in light of scientific developments occurring during its implementation;, taking into consideration, where appropriate, results of foresight reviews of the Horizon2020 Scientific Panel for Health in accordance with Article 12(2) of the Horizon 2020 Programme.
Amendment 158 #
Proposal for a Regulation
Annex 1 – part 1 – paragraph 1 – point e
Annex 1 – part 1 – paragraph 1 – point e
(e) to effectively support research and innovation in life sciences mainly through grants; at pre-clinical and clinical trial phases, where appropriate depending inter alia on need and risk.
Amendment 207 #
Proposal for a Regulation
Annex 1 – part 10 – point 1 – introductory part
Annex 1 – part 10 – point 1 – introductory part
1. The Scientific Committee shall consist of no more than 711 members appointed for a renewable period of one year. It shall elect a chairperson from amongst its members for oneup to two years.
Amendment 210 #
Proposal for a Regulation
Annex 1 – part 10 – point 4 – point a a (new)
Annex 1 – part 10 – point 4 – point a a (new)
(aa) advise on the scientific priorities to be included in the Strategic Research Agenda, taking into consideration, where appropriate, the results of the foresight reviews of the Horizon 2020 Scientific Panel for Health.